{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:11:48Z","timestamp":1792084308014,"version":"4.4.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2007,1,12]],"date-time":"2007-01-12T00:00:00Z","timestamp":1168560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,1,12]],"date-time":"2007-01-12T00:00:00Z","timestamp":1168560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1007\/s00259-006-0262-8","type":"journal-article","created":{"date-parts":[[2007,1,11]],"date-time":"2007-01-11T09:20:20Z","timestamp":1168507220000},"page":"916-925","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Effects of MDMA on blood glucose levels and brain glucose metabolism"],"prefix":"10.1007","volume":"34","author":[{"given":"M. L.","family":"Soto-Montenegro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. J.","family":"Vaquero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Arango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Ricaurte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Garc\u00eda-Barreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Desco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,1,12]]},"reference":[{"issue":"1\u20132","key":"262_CR1","first-page":"103","volume":"73","author":"CS Grob","year":"1996","unstructured":"Grob CS, Poland RE, Chang L, Ernst T. Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: methodological considerations and preliminary observations. Behav Brain Res 1996;73(1\u20132):103\u20137.","journal-title":"Behav Brain Res"},{"issue":"1","key":"262_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0163-7258(03)00003-2","volume":"98","author":"JC Cole","year":"2003","unstructured":"Cole JC, Sumnall HR. Altered states: the clinical effects of ecstasy. Pharmacol Ther 2003;98(1):35\u201358.","journal-title":"Pharmacol Ther"},{"issue":"23","key":"262_CR3","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.1016\/0006-2952(87)90566-1","volume":"36","author":"CJ Schmidt","year":"1987","unstructured":"Schmidt CJ, Taylor VL. Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine. Biochem Pharmacol 1987;36(23):4095\u2013102.","journal-title":"Biochem Pharmacol"},{"issue":"1\u20132","key":"262_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0014-2999(86)90555-8","volume":"128","author":"DM Stone","year":"1986","unstructured":"Stone DM, Stahl DC, Hanson GR, Gibb JW. The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain. Eur J Pharmacol 1986;128(1\u20132):41\u20138.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"262_CR5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3","volume":"39","author":"RB Rothman","year":"2001","unstructured":"Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI, et al. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 2001;39(1):32\u201341.","journal-title":"Synapse"},{"issue":"3","key":"262_CR6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/BF02246288","volume":"119","author":"AR Green","year":"1995","unstructured":"Green AR, Cross AJ, Goodwin GM. Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or \u201cEcstasy\u201d). Psychopharmacology (Berl) 1995;119(3):247\u201360.","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"262_CR7","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/0306-4522(96)00135-2","volume":"74","author":"T Obradovic","year":"1996","unstructured":"Obradovic T, Imel KM, White SR. Methylenedioxymethamphetamine-induced inhibition of neuronal firing in the nucleus accumbens is mediated by both serotonin and dopamine. Neuroscience 1996;74(2):469\u201381.","journal-title":"Neuroscience"},{"issue":"5","key":"262_CR8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/0301-0082(96)00027-5","volume":"49","author":"SR White","year":"1996","unstructured":"White SR, Obradovic T, Imel KM, Wheaton MJ. The effects of methylenedioxymethamphetamine (MDMA, \u201cEcstasy\u201d) on monoaminergic neurotransmission in the central nervous system. Prog Neurobiol 1996;49(5):455\u201379.","journal-title":"Prog Neurobiol"},{"issue":"6","key":"262_CR9","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1212\/WNL.51.6.1532","volume":"51","author":"KI Bolla","year":"1998","unstructured":"Bolla KI, McCann UD, Ricaurte GA. Memory impairment in abstinent MDMA (\u201cEcstasy\u201d) users. Neurology 1998;51(6):1532\u20137.","journal-title":"Neurology"},{"issue":"9138","key":"262_CR10","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/S0140-6736(98)04329-3","volume":"352","author":"UD McCann","year":"1998","unstructured":"McCann UD, Szabo Z, Scheffel U, Dannals RF, Ricaurte GA. Positron emission tomographic evidence of toxic effect of MDMA (\u201cEcstasy\u201d) on brain serotonin neurons in human beings. Lancet 1998;352(9138):1433\u20137.","journal-title":"Lancet"},{"issue":"3","key":"262_CR11","first-page":"713","volume":"249","author":"TR Insel","year":"1989","unstructured":"Insel TR, Battaglia G, Johannessen JN, Marra S, De Souza EB. 3,4-Methylenedioxymethamphetamine (\u201cecstasy\u201d) selectively destroys brain serotonin terminals in rhesus monkeys. J Pharmacol Exp Ther 1989;249(3):713\u201320.","journal-title":"J Pharmacol Exp Ther"},{"issue":"12","key":"262_CR12","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1523\/JNEUROSCI.19-12-05096.1999","volume":"19","author":"G Hatzidimitriou","year":"1999","unstructured":"Hatzidimitriou G, McCann UD, Ricaurte GA. Altered serotonin innervation patterns in the forebrain of monkeys treated with (+\/\u2212)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery. J Neurosci 1999;19(12):5096\u2013107.","journal-title":"J Neurosci"},{"key":"262_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0378-4274(99)00216-7","volume":"112\u2013113","author":"GA Ricaurte","year":"2000","unstructured":"Ricaurte GA, McCann UD, Szabo Z, Scheffel U. Toxicodynamics and long-term toxicity of the recreational drug, 3, 4-methylenedioxymethamphetamine (MDMA, \u2018Ecstasy\u2019). Toxicol Lett 2000;112\u2013113:143\u20136.","journal-title":"Toxicol Lett"},{"key":"262_CR14","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/sj.npp.1300442","volume":"29","author":"WE Fantegrossi","year":"2004","unstructured":"Fantegrossi WE, Woolverton WL, Kilbourn M, Sherman P, Yuan J, Hatzidimitriou G, et al. Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys. Neuropsychopharmacology 2004;29:1270\u201381.","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"262_CR15","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1124\/pr.55.3.3","volume":"55","author":"AR Green","year":"2003","unstructured":"Green AR, Mechan AO, Elliott JM, O\u2019Shea E, Colado MI. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d). Pharmacol Rev 2003;55(3):463\u2013508.","journal-title":"Pharmacol Rev"},{"key":"262_CR16","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s00213-003-1723-4","volume":"173","author":"MM De Win","year":"2004","unstructured":"De Win MM, Reneman L, Reitsma JB, Den Heeten GJ, Booij J, Van Den Brink W. Mood disorders and serotonin transporter density in ecstasy users\u2014the influence of long-term abstention, dose, and gender. Psychopharmacology (Berl) 2004;173:376\u201382.","journal-title":"Psychopharmacology (Berl)"},{"key":"262_CR17","doi-asserted-by":"crossref","unstructured":"Xie T, Tong L, McLane MW, Hatzidimitriou G, Yuan J, McCann U, et al. Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines. Neuropsychopharmacology 2006 Jan 25; [Epub ahead of print].","DOI":"10.1038\/sj.npp.1301031"},{"issue":"3","key":"262_CR18","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/0091-3057(89)90402-4","volume":"33","author":"AA Li","year":"1989","unstructured":"Li AA, Marek GJ, Vosmer G, Seiden LS. Long-term central 5-HT depletions resulting from repeated administration of MDMA enhances the effects of single administration of MDMA on schedule-controlled behavior of rats. Pharmacol Biochem Behav 1989;33(3):641\u20138.","journal-title":"Pharmacol Biochem Behav"},{"issue":"10","key":"262_CR19","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/0028-3908(89)90128-7","volume":"28","author":"G Wilkerson","year":"1989","unstructured":"Wilkerson G, London ED. Effects of methylenedioxymethamphetamine on local cerebral glucose utilization in the rat. Neuropharmacology 1989;28(10):1129\u201338.","journal-title":"Neuropharmacology"},{"issue":"1","key":"262_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0149-7634(95)00064-X","volume":"21","author":"DL Frederick","year":"1997","unstructured":"Frederick DL, Paule MG. Effects of MDMA on complex brain function in laboratory animals. Neurosci Biobehav Rev 1997;21(1):67\u201378.","journal-title":"Neurosci Biobehav Rev"},{"issue":"4","key":"262_CR21","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S0893-133X(00)00130-5","volume":"23","author":"A Gamma","year":"2000","unstructured":"Gamma A, Buck A, Berthold T, Liechti ME, Vollenweider FX. 3,4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H2 15O]-PET in healthy humans. Neuropsychopharmacology 2000;23(4):388\u201395.","journal-title":"Neuropsychopharmacology"},{"issue":"9152","key":"262_CR22","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/S0140-6736(05)75651-8","volume":"353","author":"J Holland","year":"1999","unstructured":"Holland J. Positron emission tomography findings in heavy users of MDMA. Lancet 1999;353(9152):592\u20133.","journal-title":"Lancet"},{"issue":"2","key":"262_CR23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1176\/jnp.14.2.125","volume":"14","author":"RA Hurley","year":"2002","unstructured":"Hurley RA, Reneman L, Taber KH. Ecstasy in the brain: a model for neuroimaging. J Neuropsychiatry Clin Neurosci 2002;14(2):125\u20139.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"13","key":"262_CR24","doi-asserted-by":"publisher","first-page":"4254","DOI":"10.1021\/jm050079o","volume":"48","author":"N Jarkas","year":"2005","unstructured":"Jarkas N, McConathy J, Voll RJ, Goodman MM. Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2\u2032-amino-4\u2032-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands. J Med Chem 2005;48(13):4254\u201365.","journal-title":"J Med Chem"},{"issue":"21","key":"262_CR25","doi-asserted-by":"publisher","first-page":"4716","DOI":"10.1021\/jm020167y","volume":"45","author":"S Oya","year":"2002","unstructured":"Oya S, Choi SR, Coenen H, Kung HF. New PET imaging agent for the serotonin transporter: [18F]ACF (2-[(2-amino-4-chloro-5-fluorophenyl)thio]N,N-dimethyl-benzenmethanamine). J Med Chem 2002;45(21):4716\u201323.","journal-title":"J Med Chem"},{"issue":"8","key":"262_CR26","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1097\/00006231-200108000-00007","volume":"22","author":"R Buchert","year":"2001","unstructured":"Buchert, R, Obrocki J, Thomasius R, Vaterlein O, Petersen K, Jenicke L, et al. Long-term effects of \u2018ecstasy\u2019 abuse on the human brain studied by FDG PET. Nucl Med Commun 2001;22(8):889\u201397.","journal-title":"Nucl Med Commun"},{"issue":"7","key":"262_CR27","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0028-3908(98)00029-X","volume":"37","author":"E O\u2019Shea","year":"1998","unstructured":"O\u2019Shea E, Granados R, Esteban B, Colado MI, Green AR. The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA (\u2018ecstasy\u2019). Neuropharmacology 1998;37(7):919\u201326.","journal-title":"Neuropharmacology"},{"key":"262_CR28","unstructured":"Soto-Montenegro M, Vaquero J, Molins A, Reig S, Desco M. FDG-PET studies of the effect of MDMA in rat brain. In: 10th Annual Meeting of the Organization for Human Brain Mapping. Hungary: Budapest; 2004."},{"issue":"3","key":"262_CR29","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1109\/23.775581","volume":"46","author":"S Siegel","year":"1999","unstructured":"Siegel S, Vaquero JJ, Aloj L, Seidel J, Gandler WR, Green MV. Initial results from a PET\/planar small animal imaging system. IEEE Trans Nucl Sci 1999;46(3):571\u2013575.","journal-title":"IEEE Trans Nucl Sci"},{"key":"262_CR30","unstructured":"L\u00f3pez Herr\u00e1iz J, Espa\u00f1a S, Ud\u00edas JM, Vaquero JJ, Seidel J, Desco M. Full 3D-OSEM reconstruction with compressed response of the system. Book of Abstracts of 2004 IEEE Nuclear Science Symposium and Medical Imaging Conference 2004:163."},{"issue":"6","key":"262_CR31","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.nucmedbio.2004.04.003","volume":"31","author":"EM Jagoda","year":"2004","unstructured":"Jagoda EM, Vaquero JJ, Seidel J, Green MV, Eckelman WC. Experiment assessment of mass effects in the rat: implications for small animal PET imaging. Nucl Med Biol 2004;31(6):771\u20139.","journal-title":"Nucl Med Biol"},{"key":"262_CR32","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1192\/bjp.175.2.186","volume":"175","author":"J Obrocki","year":"1999","unstructured":"Obrocki J, Buchert R, Vaterlein O, Thomasius R, Beyer W, Schiemann T. Ecstasy\u2014long-term effects on the human central nervous system revealed by positron emission tomography. Br J Psychiatry 1999;175:186\u20138.","journal-title":"Br J Psychiatry"},{"key":"262_CR33","unstructured":"Paxinos G, Watson C. The rat brain in stereotaxic coordinates, 4th ed. San Diego, CA: Academic Press; 1998; p 474."},{"issue":"7","key":"262_CR34","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/j.1476-5381.1995.tb15037.x","volume":"115","author":"MI Colado","year":"1995","unstructured":"Colado MI, Williams JL, Green AR. The hyperthermic and neurotoxic effects of \u2018Ecstasy\u2019 (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype. Br J Pharmacol 1995;115(7):1281\u20139.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"262_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0091-3057(99)00116-1","volume":"64","author":"A Malpass","year":"1999","unstructured":"Malpass A, White JM, Irvine RJ, Somogyi AA, Bochner F. Acute toxicity of 3,4-methylenedioxymethamphetamine (MDMA) in Sprague-Dawley and Dark Agouti rats. Pharmacol Biochem Behav 1999;64(1):29\u201334.","journal-title":"Pharmacol Biochem Behav"},{"issue":"10","key":"262_CR36","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.2042-7158.1988.tb06997.x","volume":"40","author":"M Vincent-Viry","year":"1988","unstructured":"Vincent-Viry M, Deshayes S, Mothe O, Siest G, Galteau MM. Hydroxylation of debrisoquine using perfused liver isolated from Sprague Dawley and DA rats: comparison with in-vivo results. J Pharm Pharmacol 1988;40(10):695\u2013700.","journal-title":"J Pharm Pharmacol"},{"issue":"17","key":"262_CR37","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1016\/0006-2952(86)90493-4","volume":"35","author":"AR Boobis","year":"1986","unstructured":"Boobis AR, Seddon CE, Davies DS. Bufuralol 1\u2032-hydroxylase activity of the rat. Strain differences and the effects of inhibitors. Biochem Pharmacol 1986;35(17):2961\u20135.","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"262_CR38","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/0006-2952(94)90386-7","volume":"47","author":"GT Tucker","year":"1994","unstructured":"Tucker GT, Lennard MS, Ellis SW, Woods HF, Cho AK, Lin LY, et al. The demethylenation of methylenedioxymethamphetamine (\u201cecstasy\u201d) by debrisoquine hydroxylase (CYP2D6). Biochem Pharmacol 1994;47(7):1151\u20136.","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"262_CR39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2165\/00002018-199615020-00003","volume":"15","author":"UD McCann","year":"1996","unstructured":"McCann UD, Slate SO, Ricaurte GA. Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; \u2018ecstasy\u2019). Drug Saf 1996;15(2):107\u201315.","journal-title":"Drug Saf"},{"issue":"8","key":"262_CR40","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/hup.351","volume":"16","author":"AC Parrott","year":"2001","unstructured":"Parrott AC. Human psychopharmacology of Ecstasy (MDMA): a review of 15\u00a0years of empirical research. Hum Psychopharmacol 2001;16(8):557\u201377.","journal-title":"Hum Psychopharmacol"},{"issue":"13","key":"262_CR41","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1523\/JNEUROSCI.18-13-05086.1998","volume":"18","author":"JE Malberg","year":"1998","unstructured":"Malberg JE, Seiden LS. Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat. J Neurosci 1998;18(13):5086\u201394.","journal-title":"J Neurosci"},{"issue":"1\u20132","key":"262_CR42","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/0304-3940(94)90057-4","volume":"177","author":"JF Nash","year":"1994","unstructured":"Nash JF, Roth BL, Brodkin JD, Nichols DE, Gudelsky GA. Effect of the R(\u2212) and S(+) isomers of MDA and MDMA on phosphatidyl inositol turnover in cultured cells expressing 5-HT2A or 5-HT2C receptors. Neurosci Lett 1994;177(1\u20132):111\u20135.","journal-title":"Neurosci Lett"},{"issue":"2","key":"262_CR43","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/00007691-200404000-00009","volume":"26","author":"R de la Torre","year":"2004","unstructured":"de la Torre R, Farre M, Roset PN, Pizarro N, Abanades S, Segura M, et al. Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition. Ther Drug Monit 2004;26(2):137\u201344.","journal-title":"Ther Drug Monit"},{"issue":"8816","key":"262_CR44","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/0140-6736(92)91469-O","volume":"340","author":"JA Henry","year":"1992","unstructured":"Henry JA, Jeffreys KJ, Dawling S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine (\u201cecstasy\u201d). Lancet 1992;340(8816):384\u20137.","journal-title":"Lancet"},{"issue":"3","key":"262_CR45","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1093\/bja\/60.3.274","volume":"60","author":"JJ Heffron","year":"1988","unstructured":"Heffron JJ. Malignant hyperthermia: biochemical aspects of the acute episode. Br J Anaesth 1988;60(3):274\u20138.","journal-title":"Br J Anaesth"},{"issue":"1","key":"262_CR46","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/bja\/52.1.11","volume":"52","author":"GM Hall","year":"1980","unstructured":"Hall GM, Lucke JN, Lovell R, Lister D. Porcine malignant hyperthermia. VII: hepatic metabolism. Br J Anaesth 1980;52(1):11\u20137.","journal-title":"Br J Anaesth"},{"issue":"3","key":"262_CR47","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/S0168-8278(98)80056-1","volume":"29","author":"V Andreu","year":"1998","unstructured":"Andreu V, Mas A, Bruguera M, Salmeron JM, Moreno V, Nogue S, et al. Ecstasy: a common cause of severe acute hepatotoxicity. J Hepatol 1998;29(3):394\u20137.","journal-title":"J Hepatol"},{"issue":"2","key":"262_CR48","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0735-6757(97)90117-0","volume":"15","author":"H Montgomery","year":"1997","unstructured":"Montgomery H, Myerson S. 3,4-methylenedioxymethamphetamine (MDMA, or \u201cecstasy\u201d) and associated hypoglycemia. Am J Emerg Med 1997;15(2):218.","journal-title":"Am J Emerg Med"},{"issue":"8","key":"262_CR49","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1055\/s-2002-33416","volume":"40","author":"N Lange-Brock","year":"2002","unstructured":"Lange-Brock N, Berg T, Muller AR, Fliege H, Neuhaus P, Wiedenmann B, et al. Acute liver failure following the use of ecstasy (MDMA). Z Gastroenterol 2002;40(8):581\u20136.","journal-title":"Z Gastroenterol"},{"issue":"2","key":"262_CR50","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/02791072.2002.10399951","volume":"34","author":"FX Vollenweider","year":"2002","unstructured":"Vollenweider FX, Liechti ME, Gamma A, Greer G, Geyer M. Acute psychological and neurophysiological effects of MDMA in humans. J Psychoact Drugs 2002;34(2):171\u201384.","journal-title":"J Psychoact Drugs"},{"issue":"1","key":"262_CR51","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1471-4159.1982.tb04729.x","volume":"39","author":"J McCulloch","year":"1982","unstructured":"McCulloch J, Savaki HE, Jehle J, Sokoloff L. Local cerebral glucose utilization in hypothermic and hyperthermic rats. J Neurochem 1982;39(1):255\u20138.","journal-title":"J Neurochem"},{"issue":"2","key":"262_CR52","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1152\/japplphysiol.00072.2001","volume":"92","author":"SA Nunneley","year":"2002","unstructured":"Nunneley SA, Martin CC, Slauson JW, Hearon CM, Nickerson LD, Mason PA. Changes in regional cerebral metabolism during systemic hyperthermia in humans. J Appl Physiol 2002;92(2):846\u201351.","journal-title":"J Appl Physiol"},{"issue":"9477","key":"262_CR53","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1016\/S0140-6736(05)66737-2","volume":"365","author":"GA Ricaurte","year":"2005","unstructured":"Ricaurte GA, McCann UD. Recognition and management of complications of new recreational drug use. Lancet 2005;365(9477):2137\u201345.","journal-title":"Lancet"},{"issue":"3\u20134","key":"262_CR54","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/BF01252033","volume":"63","author":"M Carlsson","year":"1985","unstructured":"Carlsson M, Svensson K, Eriksson E, Carlsson A. Rat brain serotonin: biochemical and functional evidence for a sex difference. J Neural Transm 1985;63(3\u20134):297\u2013313.","journal-title":"J Neural Transm"},{"issue":"4","key":"262_CR55","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.physbeh.2005.08.043","volume":"86","author":"T Palenicek","year":"2005","unstructured":"Palenicek T, Votava M, Bubenikova V, Horacek J. Increased sensitivity to the acute effects of MDMA (\u201cecstasy\u201d) in female rats. Physiol Behav 2005;86(4):546\u201353.","journal-title":"Physiol Behav"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-006-0262-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-006-0262-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-006-0262-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-006-0262-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,12]],"date-time":"2025-01-12T22:20:24Z","timestamp":1736720424000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-006-0262-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,12]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["262"],"URL":"https:\/\/doi.org\/10.1007\/s00259-006-0262-8","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,12]]},"assertion":[{"value":"3 May 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}